MORGAN STANLEY - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$15,799,000
-44.3%
467,442
-61.4%
0.00%
-50.0%
Q1 2021$28,340,000
-19.7%
1,211,640
-1.2%
0.00%
-20.0%
Q4 2020$35,305,000
+1067.1%
1,225,855
+720.9%
0.01%
+400.0%
Q3 2020$3,025,000
+976.5%
149,327
+1494.0%
0.00%
Q2 2020$281,000
+251.2%
9,368
+267.4%
0.00%
Q1 2020$80,000
-95.4%
2,550
-93.1%
0.00%
Q4 2019$1,741,000
+4481.6%
36,951
+534.2%
0.00%
Q3 2019$38,000
+3700.0%
5,826
+8105.6%
0.00%
Q2 2019$1,000
-97.0%
71
-97.1%
0.00%
Q1 2019$33,000
-8.3%
2,463
-72.4%
0.00%
Q4 2018$36,000
-39.0%
8,915
+1.7%
0.00%
Q3 2018$59,0008,7660.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2021
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders